Elena
Duggento

Associate
Audendum est A. Tibullo

Elena collaborates with professionals from the firm’s Life Sciences team.
She is developing specific skills and deals mainly with regulatory activities in the field of pharmaceutical law, medical devices, nutraceuticals and related scientific research.
She also deals with commercial contracts and opinions on compliance and privacy issues.

Elena joined LCA in November 2021.
Prior to graduation, she did one semester of advance law practice at a boutique firm in Milan, dealing mainly with commercial and corporate law.

Commercial and corporate Life Sciences

You might also be interested in

21.10.2026
LCA advises CDP Venture Capital and Rialto on TrueLayer’s investment round

The UK open banking fintech raises $27 million from a consortium of new and existing investors.

09.10.2026
LCA advises the selling shareholders on the sale of Planta to SIS

The transaction strengthens the maize genetics platform of the BF group’s seed division

05.10.2026
LCA alongside Impresoft in the acquisition of Marketplace Generation and Addiction ...

The group controlled by Clessidra Private Equity strengthens its e-commerce and MarTech offering  

01.10.2026
LCA Studio Legale strengthens the Corporate M&A practice with the arrival of ...

The firm consolidates the practice in extraordinary transactions and in advising Italian and U.S. investors  

25.09.2026
LCA advises the sellers on the sale of 60% of Ecupharma to Adamed Group

Majority stake sold in the Italian pharmaceutical company active in neurology, psychiatry, urology and diabetology